Trimethylglycine

Trimethylglycine is an amino acid derivative that occurs in plants. Trimethylglycine was the first betaine discovered; originally it was simply called betaine because, in the 19th century, it was discovered in sugar beets.[5] It has a sweet and umami taste. Since then, many other betaines have been discovered, and the more specific name glycine betaine distinguishes this one.

Trimethylglycine
Names
Preferred IUPAC name
(Trimethylazaniumyl)acetate
Other names
  • Betaine
  • TMG
  • glycine betaine
  • N,N,N-trimethylglycine
  • Cystadane
  • Amversio
Identifiers
CAS Number
3D model (JSmol)
Beilstein Reference
 3537113
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.003.174
EC Number
  • 203-490-6
Gmelin Reference
 26434
KEGG
MeSH Betaine
PubChem CID
UNII
InChI
  • InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3 Y
    Key: KWIUHFFTVRNATP-UHFFFAOYSA-N Y
  • InChI=1/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3
    Key: KWIUHFFTVRNATP-UHFFFAOYAI
SMILES
  • C[N+](C)(C)CC(=O)[O-]
Properties
Chemical formula
 C5H11NO2
Molar mass 117.146
Appearance White solid
Melting point 180 °C (356 °F; 453 K)[1] (decomposes)
Solubility in water
 Soluble
Solubility Methanol
Acidity (pKa) 1.84
Pharmacology
A16AA06 (WHO)
License data
By mouth
Legal status
Hazards
GHS labelling:
Pictograms
Signal word
 Warning
Hazard statements
 H315, H319
Precautionary statements
 P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362
Related compounds
Related amino acids
 Glycine
Methylglycine
Dimethylglycine
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Medical uses

Betaine is indicated for the adjunctive treatment of homocystinuria, involving deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylene-tetrahydrofolate reductase (MTHFR), or cobalamin cofactor metabolism (cbl).[2][3][4]

Structure and reactions

Trimethylglycine is an N-methylated amino acid. It is a zwitterion as the molecule contains both a quaternary ammonium group and a carboxyl group. The carboxyl group will be partially protonated in aqueous solution below pH 4, that is, approximately below pH equal to (pKa + 2).

(CH3)3N+CH2CO−2 (aq) + H+ ⇌ (CH3)3N+CH2CO2H (aq)

Demethylation of trimethylglycine gives dimethylglycine.

Production and biochemical processes

Processing sucrose from sugar beets yields glycine betaine as a byproduct. The economic value of the trimethylglycine rivals that of the sugar content in sugar beets.[6]

Biosynthesis

In most organisms, glycine betaine is biosynthesized by oxidation of choline in two steps. The intermediate, betaine aldehyde, is generated by the action of the enzyme mitochondrial choline oxidase (choline dehydrogenase, EC 1.1.99.1). Betaine aldehyde is further oxidised in the mitochondria in mice to betaine by the enzyme betaine-aldehyde dehydrogenase (EC 1.2.1.8).[7][8] In humans betaine aldehyde activity is performed by a nonspecific cystosolic aldehyde dehydrogenase enzyme (EC 1.2.1.3) [9]

Biological function

Trimethylglycine is an organic osmolyte. Sugar beet was cultivated from sea beet, which requires osmolytes in order to survive in the salty soils of coastal areas. Trimethylglycine also occurs in high concentrations (~10 mM) in many marine invertebrates, such as crustaceans and molluscs. It serves as a potent appetitive attractant to generalist carnivores such as the predatory sea slug Pleurobranchaea californica.[10]

Trimethylglycine is an important cofactor in methylation, a process that occurs in every mammalian cell donating methyl groups (–CH3) for other processes in the body. These processes include the synthesis of neurotransmitters such as dopamine and serotonin. Methylation is also required for the biosynthesis of melatonin and the electron transport chain constituent coenzyme Q10, as well as the methylation of DNA for epigenetics.

The major step in the methylation cycle is the remethylation of homocysteine, a compound which is naturally generated during demethylation of the essential amino acid methionine. Despite its natural formation, homocysteine has been linked to inflammation, depression, specific forms of dementia, and various types of vascular disease. The remethylation process that detoxifies homocysteine and converts it back to methionine can occur via either of two pathways. The pathway present in virtually all cells involves the enzyme methionine synthase (MS), which requires vitamin B12 as a cofactor, and also depends indirectly on folate and other B vitamins. The second pathway (restricted to liver and kidney in most mammals) involves betaine-homocysteine methyltransferase (BHMT) and requires trimethylglycine as a cofactor. During normal physiological conditions, the two pathways contribute equally to removal of homocysteine in the body.[11] Further degradation of betaine, via the enzyme dimethylglycine dehydrogenase produces folate, thus contributing back to methionine synthase. Betaine is thus involved in the synthesis of many biologically important molecules, and may be even more important in situations where the major pathway for the regeneration of methionine from homocysteine has been compromised by genetic polymorphisms such as mutations in the MS gene.

Trimethylglycine is produced by some cyanobacteria. Gabbay-Azaria et al 1988 uses 13C nuclear magnetic resonance to detect trimethylglycines produced by halophilic cyanobacteria. They find it is providing partial protection for their enzymes, against inhibition by NaCl and KCl.[12]

Agriculture and aquaculture

Factory farms supplement fodder with trimethylglycine and lysine to increase livestock's muscle mass (and, therefore, "carcass yield", the amount of usable meat).

Salmon farms apply trimethylglycine to relieve the osmotic pressure on the fishes' cells when workers transfer the fish from freshwater to saltwater.[6][13]

Trimethylglycine supplementation decreases the amount of adipose tissue in pigs; however, research in human subjects has shown no effect on body weight, body composition, or resting energy expenditure.[14]

Nutrition

Nutritionally, betaine is not needed when sufficient dietary choline is present for synthesis. Dietary betaine can partially, but not fully, substitute for choline.[15] When insufficient betaine is available, elevated homocysteine levels and decreased SAM levels in blood occur. Supplementation of betaine in this situation would resolve these blood marker issues, but not compensate for other functions of choline.[16]

Betaine in foods[17]
Food Betaine (mg/100 g)
Quinoa 630
Wheat germ 410
Lamb's quarters 330
Wheat bran 320
Canned Beetroot 260
Dark Rye flour 150
Spinach 110-130

Dietary supplement

Although trimethylglycine supplementation decreases the amount of adipose tissue in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.[14] The US Food and Drug Administration (FDA) approved betaine trimethylglycine (also known by the brand name Cystadane) for the treatment of homocystinuria, a disease caused by abnormally high homocysteine levels at birth.[18] Trimethylglycine is also used as the hydrochloride salt (marketed as betaine hydrochloride or betaine HCl). Betaine hydrochloride was once permitted in over-the-counter (OTC) drugs as a gastric aid in the United States. US Code of Federal Regulations, Title 21, Section 310.540, which became effective on November 10, 1993, banned betaine hydrochloride from being used in OTC products due to insufficient evidence to classify it as "generally recognized as safe and effective".[19]

Trimethylglycine supplementation may cause diarrhea, stomach upset, or nausea. Trimethylglycine supplementation lowers homocysteine but also raises LDL-cholesterol in obese individuals and renal patients.[20]

Other uses

Polymerase chain reaction

Trimethylglycine can act as an adjuvant of the polymerase chain reaction (PCR) process, and other DNA polymerase-based assays such as DNA sequencing. By an unknown mechanism, it aids in the prevention of secondary structures in the DNA molecules, and prevents problems associated with the amplification and sequencing of GC-rich regions. Trimethylglycine makes guanosine and cytidine (strong binders) behave with thermodynamics similar to those of thymidine and adenosine (weak binders). It has been determined under experiment that it is best used at a final concentration of 1 M.[21]

Medical research

Laboratory studies and two clinical trials have indicated that trimethylglycine is a potential treatment of non-alcoholic steatohepatitis.[22][23][24]

Trimethylglycine has been proposed as a treatment for depression. In theory, it would increase S-adenosylmethionine (SAMe) by remethylating homocysteine. The same homocysteine-to-methionine result could be achieved by supplementing with folic acid and vitamin B12, methionine then serving as a precursor to synthesis of SAMe. SAMe as a dietary supplement has been shown to work as a nonspecific antidepressant.[25]

References
  1. Acheson, R. M.; Bond, G. J. F. (1956). "52. Addition reactions of heterocyclic compounds. Part II. Phenanthridine and methyl acetylenedicarboxylate in methanol". J. Chem. Soc. 1956: 246. doi:10.1039/JR9560000246.
  2. "Cystadane- betaine powder, for solution". DailyMed. 3 October 2019. Archived from the original on 4 August 2021. Retrieved 29 July 2022.
  3. "Cystadane EPAR". European Medicines Agency. 17 September 2018. Archived from the original on 1 July 2022. Retrieved 29 July 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  4. "Amversio EPAR". European Medicines Agency. 21 February 2022. Archived from the original on 30 July 2022. Retrieved 29 July 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  5. Schiweck, Hubert; Clarke, Margaret; Pollach, Günter. "Sugar". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a25_345.pub2.
  6. Mäkelä, P. (2004). "Agro-industrial uses of glycinebetaine". Sugar Tech. 6 (4): 207–212. doi:10.1007/BF02942500. hdl:10138/312331. S2CID 25219649.
  7. Kempf, B.; Bremer, E. (1998). "Uptake and synthesis of compatible solutes as microbial stress responses to high-osmolality environments". Arch. Microbiol. 170 (5): 319–330. doi:10.1007/s002030050649. PMID 9818351. S2CID 8045279.
  8. "BRENDA – Information on EC 1.2.1.8 – betaine-aldehyde dehydrogenase". Brenda-enzymes.org. Archived from the original on 2016-06-29. Retrieved 2016-07-07.
  9. Chern, M. K.; Pietruszko, R. (1999). "Evidence for mitochondrial localization of betaine aldehyde dehydrogenase in rat liver: purification, characterization, and comparison with human cytoplasmic E3 isoenzyme". Biochemistry and Cell Biology. 77 (3): 179–187. doi:10.1139/o99-030. PMID 10505788.
  10. Gillette, R.; Huang, R. C.; Hatcher, N.; Moroz, L. L. (March 2000). "Cost-benefit analysis potential in feeding behavior of a predatory snail by integration of hunger, taste, and pain". Proc. Natl. Acad. Sci. USA. 97 (7): 3585–3590. Bibcode:2000PNAS...97.3585G. doi:10.1073/pnas.97.7.3585. PMC 16283. PMID 10737805.
  11. Finkelstein, J. D. (1998-03-24). "The metabolism of homocysteine: pathways and regulation". European Journal of Pediatrics. 157 (S2): S40–S44. doi:10.1007/pl00014300. ISSN 0340-6199. PMID 9587024. S2CID 38134977.
  12. Rhodes, D.; Hanson, A. D. (1993). "Quaternary Ammonium and Tertiary Sulfonium Compounds in Higher Plants". Annual Review of Plant Physiology and Plant Molecular Biology. Annual Reviews. 44 (1): 357–384. doi:10.1146/annurev.pp.44.060193.002041. ISSN 1040-2519.
  13. Xue, M.; Xie, S.; Cui, Y. (2004). "Effect of a feeding stimulant on feeding adaptation of gibel carp Carassius auratus gibelio (Bloch), fed diets with replacement of fish meal by meat and bone meal". Aquaculture Research. 35 (5): 473–482. doi:10.1111/j.1365-2109.2004.01041.x. S2CID 84304519.
  14. Schwab, U.; Törrönen, A.; Toppinen, L.; et al. (November 2002). "Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects". Am. J. Clin. Nutr. 76 (5): 961–967. doi:10.1093/ajcn/76.5.961. PMID 12399266.
  15. Rucker RB, Zempleni J, Suttie JW, McCormick DB (2007). Handbook of vitamins (4th ed.). Taylor & Francis. pp. 459–477. ISBN 9780849340222.
  16. "Dietary reference values for choline". EFSA Journal. 14 (8). 2016. doi:10.2903/j.efsa.2016.4484.
  17. "USDA Database for the Choline Content of Common Foods, Release 2 (2008)". United States Department of Agriculture. 2019-11-01. Archived from the original on 2022-07-30. Retrieved 2021-02-02.
  18. Holm, P. I.; Ueland, P. M.; Vollset, S. E.; et al. (February 2005). "Betaine and folate status as cooperative determinants of plasma homocysteine in humans". Arterioscler. Thromb. Vasc. Biol. 25 (2): 379–385. doi:10.1161/01.ATV.0000151283.33976.e6. PMID 15550695.
  19. "CFR - Code of Federal Regulations Title 21". U.S. Food & Drug Administration. Archived from the original on 2020-07-27. Retrieved 2018-09-04.
  20. Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB (2005). "Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans". PLOS Med. 2 (5): e135. doi:10.1371/journal.pmed.0020135. PMC 1140947. PMID 15916468.
  21. Henke, W.; Herdel, K.; Jung, K.; Schnorr, D.; Loening, S. A. (October 1997). "Betaine improves the PCR amplification of GC-rich DNA sequences". Nucleic Acids Res. 25 (19): 3957–3958. doi:10.1093/nar/25.19.3957. PMC 146979. PMID 9380524. Archived from the original on July 31, 2013.
  22. Angulo, P.; Lindor, K. D. (2001). "Treatment of nonalcoholic fatty liver: present and emerging therapies". Semin. Liver Dis. 21 (1): 81–88. doi:10.1055/s-2001-12931. PMID 11296699.
  23. Abdelmalek, M. F.; Sanderson, S. O.; Angulo, P.; et al. (December 2009). "Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial". Hepatology. 50 (6): 1818–26. doi:10.1002/hep.23239. PMID 19824078. S2CID 42163052.
  24. Miglio, F.; Rovati, L. C.; Santoro, A.; Setnikar, I. (August 2000). "Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study". Arzneimittelforschung. 50 (8): 722–7. doi:10.1055/s-0031-1300279. PMID 10994156.
  25. Mischoulon D, Fava M (2002). "Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence". Am. J. Clin. Nutr. 76 (5): 1158S–61S. doi:10.1093/ajcn/76.5.1158s. PMID 12420702.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.